The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak in Robotic Colorectal Surgery
Primary Purpose
Colon Neoplasms, Rectal Neoplasms, Inflammatory Bowel Disease
Status
Unknown status
Phase
Phase 2
Locations
Turkey
Study Type
Interventional
Intervention
Near-infrared ICG fluorescence imaging
Traditional bowel anastomosis
FireFly™
Sponsored by
About this trial
This is an interventional treatment trial for Colon Neoplasms focused on measuring Colorectal Disease, Robotic Surgery, Indocyanine Green Fluorescence Imaging, Anastomotic Leak, Short-term Outcomes
Eligibility Criteria
Inclusion Criteria:
- Subject is able to give informed consent for participation in the study
- Subject is willing and able to comply with the study procedures
- Subject is diagnosed with colon/rectal neoplasia, inflammatory bowel disease, diverticular disease requiring surgical excision
- Subject is scheduled for robotic colon or rectal resection
- A negative pregnancy test for women of childbearing potential prior to surgery
Exclusion Criteria:
- Subjects present with bowel obstruction or perforation
- Subject undergo emergency surgery
- Subject with ASA IV, V
- History of allergy or hypersensitivity against indocyanine green
- Pregnant or breast-feeding women
- Subject has uremia (serum creatinine >2.5 mg/dl)
- Subject is undergoing palliative surgery or who is terminally ill
- Subject who is unable to discontinue warfarin anticoagulation 5 days before surgery
- Subject taking phenobarbital, phenylbutazone, primidone, phenytoin, haloperidol, nitrofurantoin, probenecid
Sites / Locations
- Acibadem UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Bowel Anastomosis Under ICG Guidance
Standard Bowel Anastomosis
Arm Description
Patients undergo robotic colon/rectal resection and anastomosis with near-infrared ICG fluorescence imaging.
Patients undergo robotic colon/rectal resection and anastomosis without near-infrared ICG fluorescence imaging.
Outcomes
Primary Outcome Measures
Anastomotic leak rate
Anastomotic leak rate within 30 post operative days
Secondary Outcome Measures
Complication rate
Complication rate within postoperative 30 days
Mortality
Mortality within 30 post operative days
Full Information
NCT ID
NCT02598414
First Posted
November 2, 2015
Last Updated
November 22, 2015
Sponsor
Acibadem University
Collaborators
Acibadem Atakent University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02598414
Brief Title
The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak in Robotic Colorectal Surgery
Official Title
The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak and Short-term Outcomes in Robotic Colorectal Surgery: A Prospective Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
November 2015
Overall Recruitment Status
Unknown status
Study Start Date
November 2015 (undefined)
Primary Completion Date
December 2017 (Anticipated)
Study Completion Date
December 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Acibadem University
Collaborators
Acibadem Atakent University Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
In colorectal surgery, anastomotic leak and its septic consequences still remain as the most concerning complications resulting in substantial morbidity and mortality. A common determining factor for assessing the viability of a bowel anastomosis is adequate arterial perfusion to ensure sufficient local tissue oxygenation. Intraoperative near-infrared fluorescence (INIF) imaging using indocyanine green (ICG) dye is a novel technique which allows the surgeon to choose the point of transection at an optimally perfused area before creating a bowel anastomosis. Recently, the INIF imaging system has been installed on the robotic systems and this helps identify intravascular NIF signals in real time.
Although reports from several case series and retrospective cohorts have described the feasibility and safety of this imaging system during robotic colorectal surgery, to date, no studies have addressed more systematically the outcomes of this technique in robotic surgery. Considering the limitations of these reports, investigators aim to conduct a prospective randomized trial to compare robotic procedures with or without INIF imaging in patients undergoing colorectal surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colon Neoplasms, Rectal Neoplasms, Inflammatory Bowel Disease, Diverticular Disease
Keywords
Colorectal Disease, Robotic Surgery, Indocyanine Green Fluorescence Imaging, Anastomotic Leak, Short-term Outcomes
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
102 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Bowel Anastomosis Under ICG Guidance
Arm Type
Experimental
Arm Description
Patients undergo robotic colon/rectal resection and anastomosis with near-infrared ICG fluorescence imaging.
Arm Title
Standard Bowel Anastomosis
Arm Type
Active Comparator
Arm Description
Patients undergo robotic colon/rectal resection and anastomosis without near-infrared ICG fluorescence imaging.
Intervention Type
Procedure
Intervention Name(s)
Near-infrared ICG fluorescence imaging
Other Intervention Name(s)
Near-infrared fluorescence imaging, Indocyanine green
Intervention Description
Patient will have their bowel anastomosis assessed intraoperatively by near-infrared technology after indocyanine green has been injected intravenously at a concentration of 2.5 mg/ml. This procedure will be repeated twice during surgery, the first time before and the second time after the anastomosis has been done. The microvascularization at the anastomosis site will be assessed using a robotic fluorescence imaging device (FireFly™).
Intervention Type
Procedure
Intervention Name(s)
Traditional bowel anastomosis
Intervention Description
Traditional bowel anastomosis will be performed without ICG fluorescence imaging.
Intervention Type
Device
Intervention Name(s)
FireFly™
Intervention Description
The microvascularization at the anastomosis site will be assessed using a robotic fluorescence imaging device (FireFly™).
Primary Outcome Measure Information:
Title
Anastomotic leak rate
Description
Anastomotic leak rate within 30 post operative days
Time Frame
Postoperative 30 days
Secondary Outcome Measure Information:
Title
Complication rate
Description
Complication rate within postoperative 30 days
Time Frame
Postoperative 30 days
Title
Mortality
Description
Mortality within 30 post operative days
Time Frame
Postoperative 30 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subject is able to give informed consent for participation in the study
Subject is willing and able to comply with the study procedures
Subject is diagnosed with colon/rectal neoplasia, inflammatory bowel disease, diverticular disease requiring surgical excision
Subject is scheduled for robotic colon or rectal resection
A negative pregnancy test for women of childbearing potential prior to surgery
Exclusion Criteria:
Subjects present with bowel obstruction or perforation
Subject undergo emergency surgery
Subject with ASA IV, V
History of allergy or hypersensitivity against indocyanine green
Pregnant or breast-feeding women
Subject has uremia (serum creatinine >2.5 mg/dl)
Subject is undergoing palliative surgery or who is terminally ill
Subject who is unable to discontinue warfarin anticoagulation 5 days before surgery
Subject taking phenobarbital, phenylbutazone, primidone, phenytoin, haloperidol, nitrofurantoin, probenecid
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Volkan Ozben, MD
Phone
+905346484678
Email
volkanozben@yahoo.co.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bilgi Baca, MD,Prof.Dr.
Organizational Affiliation
Department of General Surgery, Acibadem University, Atakent Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Acibadem University
City
İstanbul
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
norgaz, MD
Email
tnorgaz@yahoo.com
First Name & Middle Initial & Last Name & Degree
Ali Buturak, MD
12. IPD Sharing Statement
Citations:
PubMed Identifier
24566744
Citation
Ris F, Hompes R, Cunningham C, Lindsey I, Guy R, Jones O, George B, Cahill RA, Mortensen NJ. Near-infrared (NIR) perfusion angiography in minimally invasive colorectal surgery. Surg Endosc. 2014 Jul;28(7):2221-6. doi: 10.1007/s00464-014-3432-y. Epub 2014 Feb 25.
Results Reference
result
PubMed Identifier
25451666
Citation
Jafari MD, Wexner SD, Martz JE, McLemore EC, Margolin DA, Sherwinter DA, Lee SW, Senagore AJ, Phelan MJ, Stamos MJ. Perfusion assessment in laparoscopic left-sided/anterior resection (PILLAR II): a multi-institutional study. J Am Coll Surg. 2015 Jan;220(1):82-92.e1. doi: 10.1016/j.jamcollsurg.2014.09.015. Epub 2014 Sep 28.
Results Reference
result
Learn more about this trial
The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak in Robotic Colorectal Surgery
We'll reach out to this number within 24 hrs